Amneal to Report Third Quarter 2025 Results on October 30, 2025
Amneal Pharmaceuticals (NASDAQ: AMRX), a global biopharmaceutical company, has scheduled its third quarter 2025 financial results announcement for Thursday, October 30, 2025, before market open.
The company will host an audio webcast at 8:30 a.m. ET accessible through their Investor Relations website. Participants can join via webcast or dial in using 1 (833) 470-1428 in the U.S. with access code 272787. International toll-free numbers are available, and a replay will be provided after the call.
Amneal Pharmaceuticals (NASDAQ: AMRX), una realtà globale nel settore biofarmaceutico, ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2025 per giovedì 30 ottobre 2025, prima dell'apertura del mercato.
La società ospiterà una webcast audio alle ore 8:30 ET accessibile dal proprio sito di Relazioni con gli Investitori. I partecipanti potranno unirsi tramite webcast o chiamare al numero 1 (833) 470-1428 negli Stati Uniti con il codice di accesso 272787. Sono disponibili numeri internazionali gratuiti e una replica sarà fornita dopo la chiamata.
Amneal Pharmaceuticals (NASDAQ: AMRX), una empresa global de biofarmacéutica, ha programado el anuncio de resultados financieros del tercer trimestre de 2025 para el jueves 30 de octubre de 2025, antes de la apertura del mercado.
La compañía organizará una transmisión de audio en la web a las 8:30 a.m. ET accesible desde su sitio de Relaciones con Inversores. Los participantes pueden unirse por webcast o llamar al 1 (833) 470-1428 en EE. UU. con el código de acceso 272787. Hay números internacionales gratuitos disponibles y habrá una repetición después de la llamada.
Amneal Pharmaceuticals (NASDAQ: AMRX), 글로벌 생물의약품 기업으로, 2025년 3분기 실적 발표를 2025년 10월 30일 목요일 장 시작 전에 예정했습니다.
회사는 투자자 관계 웹사이트를 통해 접속 가능한 오디오 웹캐스트를 동부 표준시 8:30에 진행합니다. 참가자는 웹캐스트로 참여하거나 미국에서 1 (833) 470-1428번으로 접속 코드 272787를 사용해 전화로 참여할 수 있습니다. 국제 무료 번호도 제공되며, 발표 후 재방송이 제공됩니다.
Amneal Pharmaceuticals (NASDAQ : AMRX), une société biopharmaceutique mondiale, prévoit d'annoncer ses résultats financiers du troisième trimestre 2025 le jeudi 30 octobre 2025, avant l’ouverture du marché.
L'entreprise proposera une diffusion audio en ligne à 8h30 HE accessible via son site des Relations Investisseurs. Les participants peuvent rejoindre par webcast ou composer le 1 (833) 470-1428 aux États-Unis avec le code d'accès 272787. Des numéros internationaux sans frais sont disponibles et une rediffusion sera proposée après l'appel.
Amneal Pharmaceuticals (NASDAQ: AMRX), ein weltweit tätiges Biopharmaunternehmen, hat die Veröffentlichung der Finanzergebnisse für das dritte Quartal 2025 für Donnerstag, den 30. Oktober 2025, vor Handelsbeginn vorgesehen.
Das Unternehmen wird einen akustischen Webcast um 8:30 Uhr ET anbieten, der über die Website Investor Relations zugänglich ist. Teilnehmer können per Webcast beitreten oder in den USA unter der Nummer 1 (833) 470-1428 mit dem Zugangscode 272787 telefonieren. Internationale gebührenfreie Nummern sind verfügbar, und eine Wiederholung wird nach dem Anruf bereitgestellt.
Amneal Pharmaceuticals (NASDAQ: AMRX)، شركة أدوية حيوية عالمية، قد أصدرت إعلان نتائجها المالية للربع الثالث من عام 2025 يوم الخميس 30 أكتوبر 2025 قبل افتتاح السوق.
ستستضيف الشركة بثًا صوتيًا عبر الويب في الساعة 8:30 صباحًا بتوقيت شرق الولايات المتحدة يمكن الوصول إليه عبر موقعها الخاص بالعلاقات مع المستثمرين. يمكن للمشاركين الانضمام عبر البث أو الاتصال بالرقم 1 (833) 470-1428 في الولايات المتحدة مع رمز الدخول 272787. تتوفر أرقام دولية مجانية، وسيتم توفير إعادة تشغيل بعد الاتصال.
Amneal Pharmaceuticals (NASDAQ: AMRX)，一家全球生物制药公司，已将其 2025 年第三季度财务业绩发布 定于 2025 年 10 月 30 日周四，开市前发布。
公司将于 美国东部时间 8:30 提供音频网络广播，可通过其投资者关系网站访问。参与者可以通过网络广播加入，或在美国拨打 1 (833) 470-1428，访问代码为 272787。提供国际免费电话，通话结束后将提供重播。
- None.
- None.
BRIDGEWATER, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its third quarter 2025 financial results on Thursday, October 30, 2025, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET.
The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com. Individuals may register for the webcast by clicking the link here. To access the call through a conference line, dial 1 (833) 470-1428 (in the U.S.) or for a list of toll-free international numbers, visit this here. The access code for the call is 272787. A replay of the conference call will be posted shortly after the call.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com and follow us on LinkedIn.
Investor Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com
FAQ
When will Amneal Pharmaceuticals (AMRX) report Q3 2025 earnings?
How can investors access Amneal's Q3 2025 earnings call?
Where can I find the replay of Amneal's Q3 2025 earnings call?
What time is Amneal's Q3 2025 earnings call?
